Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein

[1]  E. Kenigsberg,et al.  Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease , 2019, Cell.

[2]  P. Shridas,et al.  Role of serum amyloid A in atherosclerosis. , 2019, Current opinion in lipidology.

[3]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[4]  D. Wasserman,et al.  CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet , 2018, Diabetes.

[5]  G. Sack.  Serum amyloid A – a review , 2018, Molecular medicine.

[6]  P. McNamara,et al.  Serum Amyloid A Is an Exchangeable Apolipoprotein , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Shridas,et al.  High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation , 2018, The Journal of Biological Chemistry.

[8]  P. Shridas,et al.  Serum amyloid A3 is pro-atherogenic. , 2018, Atherosclerosis.

[9]  F. Chen,et al.  Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease , 2018 .

[10]  V. Chair,et al.  Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[11]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[12]  G. Getz,et al.  Serum amyloid A and atherosclerosis , 2016, Current opinion in lipidology.

[13]  A. Peters,et al.  Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. , 2015, European heart journal.

[14]  G. Getz,et al.  Serum Amyloid A Facilitates Early Lesion Development in Ldlr−/− Mice , 2015, Journal of the American Heart Association.

[15]  N. Webb,et al.  A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S] , 2015, Journal of Lipid Research.

[16]  P. Disterer,et al.  Pathogenetic mechanisms of amyloid A amyloidosis , 2013, Proceedings of the National Academy of Sciences.

[17]  N. Webb,et al.  SAA does not induce cytokine production in physiological conditions. , 2013, Cytokine.

[18]  P. Kovanen,et al.  Immune functions of serum amyloid A. , 2012, Critical reviews in immunology.

[19]  A. Campa,et al.  High-density lipoprotein prevents SAA-induced production of TNF-α in THP-1 monocytic cells and peripheral blood mononuclear cells. , 2011, Memorias do Instituto Oswaldo Cruz.

[20]  C. Zhang,et al.  Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice , 2011, Molecular medicine.

[21]  Hak Jung Kim,et al.  A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production , 2010, Experimental & Molecular Medicine.

[22]  V. King,et al.  A Murine Model of Obesity With Accelerated Atherosclerosis , 2010, Obesity.

[23]  P. Witting,et al.  Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. , 2009, Atherosclerosis.

[24]  N. Webb,et al.  HDL Remodeling During the Acute Phase Response , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Sun Young Lee,et al.  Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes1 , 2008, The Journal of Immunology.

[26]  R. Ye,et al.  Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1 , 2008, The Journal of Immunology.

[27]  H. P. Monteiro,et al.  Is serum amyloid A an endogenous TLR4 agonist? , 2008, Journal of leukocyte biology.

[28]  F. D. de Beer,et al.  Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake* , 2005, Journal of Biological Chemistry.

[29]  A. Chait,et al.  Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice , 2004, Circulation.

[30]  S. Reis,et al.  Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[31]  D. Rader,et al.  Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[32]  P. Barter,et al.  Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. , 2002, Atherosclerosis. Supplements.

[33]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[34]  A. Tall,et al.  Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[35]  P. Barter,et al.  The Influence of Cholesteryl Ester Transfer Protein on the Composition, Size, and Structure of Spherical, Reconstituted High Density Lipoproteins (*) , 1995, The Journal of Biological Chemistry.

[36]  R. Badolato,et al.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.

[37]  P. Sharp,et al.  Evolution of the serum amyloid A (SAA) protein superfamily. , 1994, Genomics.

[38]  A. Tall.  Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.

[39]  K. Marotti,et al.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein , 1993, Nature.

[40]  G. Coetzee,et al.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.

[41]  N. Eriksen,et al.  Amyloid protein SAA is associated with high density lipoprotein from human serum. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[42]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.